ACM
RCKT icon

ADAR1 Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

ADAR1 Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
435,500
+3,000
+0.7% +$9.98K 0.07% 151
2026
Q1 		$1.55M Sell
432,500
-43,300
-9% -$172K 0.09% 130
2025
Q4 		$1.67M Sell
475,800
-100,000
-17% -$342K 0.12% 110
2025
Q3 		$1.88M Buy
575,800
+300,000
+109% +$945K 0.18% 81
2025
Q2 		$676K Buy
275,800
+34,000
+14% +$172K 0.1% 101
2025
Q1 		$1.61M Buy
241,800
+30,400
+14% +$300K 0.3% 65
2024
Q4 		$2.66M Buy
211,400
+207,100
+4,816% +$3.12M 0.53% 42
2024
Q3 		$79.4K Buy
4,300
+4,200
+4,200% +$86K 0.01% 196
2024
Q2 		$2.15K Buy
+100
New +$2.3K ﹤0.01% 256

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

ADAR1 Capital Management's RCKT Position: Q2 2026 in Review

ADAR1 Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 0.69% in Q2 2026, buying an estimated $9.98K and bringing the position to 435,500 shares worth $1.49M. The position accounts for 0.07% of the portfolio, ranked #151.

ADAR1 Capital Management first reported a position in RCKT in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.66M in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • ADAR1 Capital Management held 435,500 shares of Rocket Pharmaceuticals worth $1.49M as of Q2 2026.
  • ADAR1 Capital Management bought 3,000 Rocket Pharmaceuticals shares in Q2 2026, an estimated $9.98K.
  • Rocket Pharmaceuticals made up 0.07% of ADAR1 Capital Management's portfolio in Q2 2026, its #151 holding.
  • ADAR1 Capital Management first reported a position in Rocket Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • ADAR1 Capital Management's Rocket Pharmaceuticals position peaked at $2.66M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.